Hsa_circ_0001946 Inhibits Lung Cancer Progression and Mediates Cisplatin Sensitivity in Non-small Cell Lung Cancer via the Nucleotide Excision Repair Signaling Pathway

Background: Despite great advances in the diagnosis and treatment of non-small cell lung cancer (NSCLC), early diagnosis remains a challenge because patients usually have advanced lung cancer at the time they are diagnosed. The limited efficacy of conventional chemotherapy is another major problem i...

Full description

Bibliographic Details
Main Authors: Ma-Sha Huang, Jun-Yan Liu, Xiao-Bo Xia, Ying-Zi Liu, Xi Li, Ji-Ye Yin, Jing-Bo Peng, Lin Wu, Wei Zhang, Hong-Hao Zhou, Zhao-Qian Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-06-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00508/full